Obagi Nu-Derm Clear
Obagi Clear (Step 3 in the Obagi Nu-Derm system) is a skin bleaching and correcting cream that contains hydroquinone. Obagi Clear helps correct the appearance of age and sun spots for a healthier, more even skin tone.
Please Note: Obagi prescription products are not available in AK, AL, AR, GA, HI, MS, NC, ND, OK, SC, WI.
This product contains ingredients regulated by the FDA and is only available by prescription. In order to qualify your prescription we require a free online video consultation with our Certified Medical professionals. Video Consultation is a complementary service and included with the purchase of this product.
Use this deep-penetrating, powerful prescription-strength facial cream alone or as part of the complete Obagi Nu-Derm regimen. Its 4% hydroquinone formula eliminates and prevents age spots, dark spots, hyper-pigmentation, uneven skin tone, and discoloration. Daily use of this skin lightening and correcting agent will help restore and rebuild melanin in the skin, allowing for a more radiant, evenly-toned complexion.
Obagi Nu-Derm Clear Rx penetrates deep into the third layer of the skin for lasting and effective treatment. It’s safe for daily use and ideal for all skin types.
Side Effects and Product Safety: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.
Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.
